Elías Delgado Selected Research

type 2 taste receptors

1/2016

Genetic variations of the bitter taste receptor TAS2R38 are associated with obesity and impact on single immune traits.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elías Delgado Research Topics

Disease

12	Type 2 Diabetes Mellitus (MODY) 03/2022 - 11/2006
10	Insulin Resistance 05/2019 - 02/2004
6	Weight Loss (Weight Reduction) 01/2019 - 04/2010
5	Obesity 01/2021 - 11/2006
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 11/2009
4	Diabetes Mellitus 08/2020 - 01/2011
4	Prediabetic State (Prediabetes) 05/2019 - 09/2011
3	Hypertension (High Blood Pressure) 10/2021 - 06/2016
2	Heart Failure 07/2022 - 01/2018
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2021 - 04/2019
2	Neoplasms (Cancer) 01/2021 - 01/2019
2	Dyslipidemias (Dyslipidemia) 02/2015 - 05/2014
2	Vascular Diseases (Vascular Disease) 02/2013 - 09/2011
2	Glucose Intolerance 01/2011 - 11/2009
1	Thyroid Hormone Resistance Syndrome (Thyroid Hormone Resistance) 12/2021
1	Thyroid Diseases (Thyroid Disease) 12/2021
1	Hypercholesterolemia 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Heart Diseases (Heart Disease) 08/2020
1	Hypoglycemia (Reactive Hypoglycemia) 04/2019
1	Body Weight (Weight, Body) 04/2019
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2018
1	Infections 01/2018
1	Weight Gain 06/2013
1	Coronary Disease (Coronary Heart Disease) 02/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2011
1	Inflammation (Inflammations) 04/2010
1	Liver Diseases (Liver Disease) 10/2008
1	Ketosis 06/2006
1	Necrosis 02/2004

Drug/Important Bio-Agent (IBA)

16	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 03/2008
5	Insulin (Novolin)FDA Link 04/2019 - 02/2004
4	AdiponectinIBA 10/2008 - 02/2004
3	Insulin Glargine (Lantus)FDA Link 11/2021 - 01/2019
3	Sodium-Glucose Transporter 2 InhibitorsIBA 08/2020 - 01/2018
3	Hypoglycemic Agents (Hypoglycemics)IBA 04/2019 - 01/2014
3	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2016 - 04/2010
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 02/2015 - 09/2011
2	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2014
2	ORALIT (ORS)IBA 10/2021 - 05/2019
2	Sodium-Glucose Transport ProteinsIBA 01/2019 - 01/2018
2	Triglycerides (Triacylglycerol)IBA 09/2014 - 02/2013
2	C-Reactive ProteinIBA 09/2014 - 01/2013
2	LipidsIBA 05/2014 - 04/2010
2	CytokinesIBA 01/2014 - 02/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2007 - 11/2006
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2022
1	Dietary Fats (Dietary Fat)IBA 03/2022
1	AntibodiesIBA 12/2021
1	Thyroid HormonesIBA 12/2021
1	insulin degludecIBA 11/2021
1	Particulate MatterIBA 10/2021
1	iodized salt (iodised salt)IBA 01/2021
1	SodiumIBA 08/2020
1	Antihypertensive Agents (Antihypertensives)IBA 06/2016
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 01/2016
1	type 2 taste receptorsIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	HDL CholesterolIBA 09/2014
1	oxidized low density lipoproteinIBA 05/2014
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2014
1	Coffee FDA Link 01/2014
1	Testosterone (Sustanon)FDA Link 01/2011
1	Sex Hormone-Binding GlobulinIBA 01/2011
1	AndrogensIBA 01/2011
1	Insulysin (Insulin-Degrading Enzyme)IBA 04/2010
1	Hydrocortisone (Cortisol)FDA LinkGeneric 04/2010
1	Transaminases (Aminotransferases)IBA 10/2008
1	Adiponectin ReceptorsIBA 10/2008
1	Aspartic Acid (Aspartate)FDA Link 10/2008
1	Alanine (L-Alanine)FDA Link 10/2008
1	Protein Isoforms (Isoforms)IBA 04/2007
1	ImmunosorbentsIBA 02/2004
1	EnzymesIBA 02/2004
1	factor AIBA 02/2004
1	Alanine Transaminase (SGPT)IBA 02/2004

Therapy/Procedure

3	Therapeutics 07/2022 - 06/2016
1	Glycemic Control 11/2021
1	Mediterranean Diet 01/2021
1	Drug Therapy (Chemotherapy) 06/2016
1	Percutaneous Coronary Intervention 02/2015